i-SEP - the alternative to allogeneic blood transfusions

i-SEP is a French Medtech, based in Nantes (Upper Brittany, France) specialized in intraoperative cell salvage (IOCS) and Patient Blood Management (PBM) .
i-SEP has developed and patented an innovative technology for the separation of blood components.

Technology

01

same™

i-SEP is developing a new generation of intraoperative cell salvage technology (IOCS) for use in hemorrhagic or high-risk hemorrhagic surgery, capable of recovering not only red blood cells but also the patient's platelets.

Events & news

Chronicle

11.02.22

🚨🩸“Every donation is critical and you can make a lifesaving difference.”...

🚨🩸“Every donation is critical and you can make a lifesaving difference.”... This is what appears first on the American Red Cross website, experiencing, since January 2022, its first ever national blood crisis. At…

Event

29.10.21

EACTAIC/ICCVA congress 2021

🌍🩸A world premiere: This morning the first communication of our clinical results have been presenting by Doctor Alexandre Mansour in the "Masterclass Workshop transfusion & Hemostasis" session of the EACTAIC…

News

05.09.22

Same™ by I-SEP medical device has obtained the CE mark and started marketing

i-SEP announces the CE marking and marketing of its autotransfusion medical device: same™ by i-SEP. For the past several months I-SEP has been preparing to market its highly innovative and unique…

All news

Expertise :
autotransfusion,
the alternative
to allogenic
transfusions

Learn more

Innovative solutions & efficiency for the patient

Technology

Events & news

Download a
press release